HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Xavier Ducrocq Jean-Marie Wihlm Gilbert Massard Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Mansour, Z. Articles by Massard, G. Search for Related Content PubMed PubMed Citation Articles by Mansour, Z. Articles by Massard, G. Related Collections Lung - cancer

Eur J Cardiothorac Surg 2007;31:181-185. doi:10.1016/j.ejcts.2006.11.008
Copyright © 2007, European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved

Induction chemotherapy does not increase the operative risk of pneumonectomy!

Service de Chirurgie Thoracique, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg, France

Received 27 July 2006; received in revised form 27 October 2006; accepted 7 November 2006.

^_* Corresponding author. Tel.: +33 3 88 11 62 02; fax: +33 3 88 11 60 77. (Email: Gilbert.Massard{at}chru-strasbourg.fr).

Background: There is an ongoing debate whether induction therapy increases post-operative mortality and morbidity, especially when performing pneumonectomy. We therefore reviewed a consecutive series of patients having undergone pneumonectomy in a single center. Methods: The charts of 298 patients operated on between January 1999 and July 2005 were reviewed. Patients were divided into two groups: group 1 included those who received induction chemotherapy (60 patients, 20.1%), and group 2 included those who underwent surgery alone (238 patients, 79.9%). Endpoints were operative mortality at 30 and at 90 days, and major complications such as empyema, bronchial fistula and acute respiratory distress syndrome. Statistical analyses were performed using SPSS 11.0 software. Results: Demographic data were similar for both groups when considering side of operation, comorbidity and weaning from tobacco; patients were older in group 2 (61.83 ± 9.58 years vs 57.75 ± 8.94 years; p = 0.003) and there were more female patients in group 2 (17.2% vs 5.0%; p = 0.010). Post-operative mortality at 30 days was 6.7% in group 1 and 5.5% in group 2 (p = 0.458), and 11.7% for group 1 and 10.9% in group 2 at 90 days (p = 0.512). Incidence of empyema was 1.7% in group 1 and 2.1% in group 2 (p = 0.652); incidence of bronchopleural fistulas was 1.7% in group 1 and 5.5% in group 2 (p = 0.188); incidence of acute respiratory distress syndrome was 3.3% in group 1 and 3.4% in group 2 (p = 0.675). Conclusion: In opposition to previous reports, induction chemotherapy did not significantly jeopardize post-operative outcome following pneumonectomy in our experience.

Key Words: Pneumonectomy • Chemotherapy • Surgery • Complications

This article has been cited by other articles:

				T. Gudbjartsson, E. Gyllstedt, A. Pikwer, and P. Jonsson Early surgical results after pneumonectomy for non-small cell lung cancer are not affected by preoperative radiotherapy and chemotherapy. Ann. Thorac. Surg., August 1, 2008; 86(2): 376 - 382. [Abstract] [Full Text] [PDF]

				Z. Mansour, E. A. Kochetkova, N. Santelmo, X. Ducrocq, E. Quoix, J.-M. Wihlm, and G. Massard Persistent n2 disease after induction therapy does not jeopardize early and medium term outcomes of pneumonectomy. Ann. Thorac. Surg., July 1, 2008; 86(1): 228 - 233. [Abstract] [Full Text] [PDF]

				N. Pourel, N. Santelmo, N. Naafa, A. Serre, W. Hilgers, L. Mineur, N. Molinari, and F. Reboul Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response Eur. J. Cardiothorac. Surg., May 1, 2008; 33(5): 829 - 836. [Abstract] [Full Text] [PDF]

				P. E. Van Schil Mortality associated with pneumonectomy after induction chemoradiation versus chemotherapy alone in stage IIIA-N2 non-small cell lung cancer J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 718 - 718. [Full Text] [PDF]

				P. E. Van Schil Operative risk of pneumonectomy after induction chemoradiotherapy Eur. J. Cardiothorac. Surg., September 1, 2007; 32(3): 550 - 550. [Full Text] [PDF]